Advances in lysosomal escape mechanisms for gynecological cancer nano-therapeutics
Journal of Pharmaceutical Analysis · 2024-12 · 14 (12) · 101119
DOI: 10.1016/j.jpha.2024.101119 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Pharmaceutical Analysis, 2024-12. Verfasst von Heng Wei und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, 117004, China. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Gynecological cancers present significant treatment challenges due to drug resistance and adverse side effects. This review explores advancements in lysosomal escape mechanisms, essential for enhancing nano-therapeutic efficacy. Strategies such as pH-sensitive linkers and membrane fusion are examined, showcasing their potential to improve therapeutic outcomes in ovarian, cervical, and uterine cancers. We delve into novel materials and strategies developed to bypass the lysosomal barrier, including pH-sensitive linkers, fusogenic lipids, and nanoparticles (NPs) engineered for endosomal disruption. Mechanisms such as the proton sponge effect, where NPs induce osmotic swelling and rupture of the lysosomal membrane, and membrane fusion, which facilitates the release of therapeutic agents directly into the cytoplasm, are explored in detail. These innovations not only promise to improve therapeutic outcomes but also minimize side effects, marking a significant step forward in the treatment of ovarian, cervical, and uterine cancers. By providing a comprehensive analysis of current advancements and their implications for clinical applications, this review sheds light on the potential of lysosomal escape strategies to revolutionize gynecological cancer treatment, setting the stage for future research and development in this vital area.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, 117004, China.
Zitieren
APA
Wei, H., Hao, Y., Zhang, J., Qi, Y., Feng, C., & Zhang, C. (2024). Advances in lysosomal escape mechanisms for gynecological cancer nano-therapeutics. Journal of Pharmaceutical Analysis, 14(12), 101119. https://doi.org/10.1016/j.jpha.2024.101119
Vancouver
Wei H, Hao Y, Zhang J, Qi Y, Feng C, Zhang C. Advances in lysosomal escape mechanisms for gynecological cancer nano-therapeutics. Journal of Pharmaceutical Analysis. 2024;14(12):101119. doi:10.1016/j.jpha.2024.101119
BibTeX
@article{Wei2024,
author = {Wei, Heng and Hao, Yingying and Zhang, Jin and Qi, Yue and Feng, Chong and Zhang, Chen},
title = {Advances in lysosomal escape mechanisms for gynecological cancer nano-therapeutics},
journal = {Journal of Pharmaceutical Analysis},
year = {2024},
volume = {14},
number = {12},
pages = {101119},
doi = {10.1016/j.jpha.2024.101119}
}
EUVIMED